GALK2
N-acetylgalactosamine kinase
Also known as: GALK2_HUMAN, GK2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q01415
- Gene
- GALK2
- Ensembl
- ENSG00000156958
- Chromosome
- 15
- Canonical length
- 458 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
This gene encodes a highly efficient N-acetylgalactosamine (GalNAc) kinase, which has galactokinase activity when galactose is present at high concentrations. The encoded protein is a member of the GHMP kinase family. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
Canonical amino-acid sequenceUniProt
458 residues, UniProt reviewed canonical sequence.
>Q01415|GALK2
1 MATESPATRR VQVAEHPRLL KLKEMFNSKF GSIPKFYVRA PGRVNIIGEH IDYCGYSVLP
61 MAVEQDVLIA VEPVKTYALQ LANTNPLYPD FSTSANNIQI DKTKPLWHNY FLCGLKGIQE
121 HFGLSNLTGM NCLVDGNIPP SSGLSSSSAL VCCAGLVTLT VLGRNLSKVE LAEICAKSER
181 YIGTEGGGMD QSISFLAEEG TAKLIEFSPL RATDVKLPSG AVFVIANSCV EMNKAATSHF
241 NIRVMECRLA AKLLAKYKSL QWDKVLRLEE VQAKLGISLE EMLLVTEDAL HPEPYNPEEI
301 CRCLGISLEE LRTQILSPNT QDVLIFKLYQ RAKHVYSEAA RVLQFKKICE EAPENMVQLL
361 GELMNQSHMS CRDMYECSCP ELDQLVDICR KFGAQGSRLT GAGWGGCTVS MVPADKLPSF
421 LANVHKAYYQ RSDGSLAPEK QSLFATKPGG GALVLLEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against GALK2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- kidney: 28 nTPM
- choroid plexus: 21 nTPM
- liver: 20 nTPM
- duodenum: 19 nTPM
- parathyroid gland: 17 nTPM
- adrenal gland: 16 nTPM
Single-cell type
- choroid plexus epithelial cells: 230 nCPM
- somatotrophs: 219 nCPM
- thyrotrophs: 216 nCPM
- lactotrophs: 194 nCPM
- gonadotrophs: 192 nCPM
- respiratory ciliated cells: 171 nCPM
Immune cell
- basophil: 46 nTPM
- T-reg: 35 nTPM
- eosinophil: 29 nTPM
- NK-cell: 20 nTPM
- MAIT T-cell: 19 nTPM
- gdT-cell: 18 nTPM
Brain region
- choroid plexus: 33 nTPM
- white matter: 24 nTPM
- cerebellum: 22 nTPM
- cerebral cortex: 21 nTPM
- basal ganglia: 21 nTPM
- midbrain: 20 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.25
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.39
- DepMap mean gene effect
- -0.12
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- galactokinase activity
- N-acetylgalactosamine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Galactokinase
- GHMP kinase, ATP-binding, conserved site
- GHMP kinase N-terminal domain
- Mevalonate/galactokinase
- GHMP kinase, C-terminal domain
- Small ribosomal subunit protein uS5 domain 2-type fold, subgroup
- Galactokinase, N-terminal domain
- Galactokinase, conserved site
- Ribosomal protein uS5 domain 2-type superfamily
- GHMP kinase, C-terminal domain superfamily
- GHMP kinases N terminal domain
- GHMP kinases C terminal
- Galactokinase galactose-binding signature
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GALK2 as an antibody target. Whether an autoantibody or antibody against GALK2 could matter depends on whether native GALK2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GALK2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GALK2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...